PATH is currently recruiting for a Vaccine Financing and Partnerships Director to lead PATH’s engagement in solving for current market failures that stop or significantly slow the late stage development and introduction of vaccine candidates targeted for public markets in low- and lower-middle income countries (LLMICs). These vaccine candidates can have tremendous impact on reducing death and disability in populations with the greatest need and least ability to pay. Although the global community has made great strides in creating mechanisms to overcome some market failures, those solutions may be necessary but are not sufficient to address the market characteristics of the disease/vaccine targets currently in development. New solutions are needed. The Vaccine Financing and Partnerships Director’s primary interest is to ensure candidates and products in the PATH/CVIA portfolio have the optimal impact in LLMICs.
The Vaccine Financing and Partnerships Director will work with leaders and staff to fully understand CVIA’s current and potential future portfolio. They will engage with specific vaccine projects and product areas to help identify, analyze, and find solutions for current or anticipated gaps. They will bring the experience and potential solutions from the portfolio to the global conversation – representing PATH at any existing forums and advocate for, and seek to facilitate dialogue where there is insufficient attention currently being paid along the vaccine development and introduction continuum.
PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.
PATH’s Center for Vaccine Innovation and Access brings together our expertise across every stage of the long and complex process of vaccine research, development, and delivery to make lifesaving vaccines widely available to children and communities across the world. CVIA’s current portfolio encompasses more than two dozen vaccines either in development or already in use to protect against 15 different diseases. Our focus is on vaccines to address the leading diseases that claim children’s lives worldwide: pneumonia, diarrheal disease, and malaria; as well as other global health priorities, such as polio and meningitis. We work in partnership with national health ministries, pharmaceutical manufacturers, donors, international financing and regulatory organizations, and many others. PATH has led numerous global partnerships, including the award-winning Meningitis Vaccine Project and the Malaria Vaccine Initiative, which helped develop the first malaria vaccine candidate recommended for pilot implementation.
- Review development and introduction projects across all functional areas and recommend viable options for optimal partnerships/financing to drive impact of CVIA current and future portfolio.
- Engage with product-specific teams to assist them in development of life-cycle management plans; at the outset, with a focus on Japanese encephalitis and HPV.
- For HPV specifically, work with the partners to contribute to a long-term plan for LMIC market success and impact, through optimizing partnerships.
- Advise teams on future opportunities for financing and markets as they build new research partnerships.
- Contribute to key vaccine development tactical documents to align any recommendations on partnerships and financing within this context.
- Other duties as assigned.
Leading the Global Dialogue
- Convene stakeholders to help develop and implement solutions to bridge important partnership and financing gaps that limit impact of products and optimize/accelerate decision-making across the regulatory-policy-financing pathway.
- In support of CVIA leadership, lead PATH’s engagement and contribution to the global forums and dialogues, including DCVMN, about building sustainable business models for global health vaccines.
- Formulate potential solutions to bring to the global discussion, informed by the PATH portfolio. Within this context, engage with the regulators, policy-makers, funders, and DCVMs.
- Engage in the forums about models for DCVM sustainability; bring global knowledge and potential solutions back to CVIA projects and partnerships to drive impact of CVIA portfolio.
- Other duties as assigned.